Interleukin-15

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Synonym(s)

IL-15

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Interleukin-15 is 14-15 kDa, pleiotropic, proinflammatory cytokine (glycoprotein). The cytokine is mainly expressed in muscle and placental tissue, but not on T-lymphocytes. The gene coding for interleukin-15 is located on chromosome 4.

General informationThis section has been translated automatically.

Interleukin-15 binds to several receptors, for example to lymphoid cells via the tetratrimeric receptor IL-2/IL-14Rbeta. In bone marrow stromal cells and thymus cells, interleukin-15 binds to receptors that have no affinity for interleukin-2. Furthermore, the cytokine activates mast cells. The induction of mast cells is mediated by another type of receptor.

Interleukin-15 has a broad biological effect on various cell systems. Interleukin-15 stimulates, among other things, the proliferation of T and B lymphocytes and NK cells in the blood (and also in tissue).

The cytokine plays a dominant role in the development of inflammatory responses to microbial agents or invading parasites by modulating the response of both the adaptive and innate immune response.

Interleukin-15 differentiated dendritic cells are potential vaccine candidates in tumor therapy.

LiteratureThis section has been translated automatically.

  1. Anguille S et al,(2013) Interleukin-15 dendritic cells as vaccine candidates for cancer immunotherapy. Hum Vaccine Immunother 9:1956-1961.
  2. Carroll HP et al (2008) Signalling, inflammation and arthritis: Crossed signals: the role of interleukin-15 and -18 in autoimmunity. Rheumatology (Oxford) 47:1269-1277.
  3. Meresse B et al (2015) Interleukin-15, a master piece in the immunological jigsaw of celiac disease. Dig Dis 33:122-130.
  4. Perera PY et al (2012) The role of interleukin-15 in inflammation and immune responses to infection: implications for its therapeutic use. Microbes Infect 14:247-261.
  5. Van den Bergh JM et al (2014) Interleukin-15: new kid on the block for antitumor combination therapy. Cytokine Growth Factor Rev 26:15-24.
  6. Waldmann TA (2014) Interleukin-15 in the treatment of cancer. Expert Rev Clin Immunol 10:1689-1701.
  7. Ye J (2015) Beneficial metabolic activities of inflammatory cytokines interleukin 15 in obesity and type 2 diabetes. Front Med 9:139-145.

Authors

Last updated on: 29.10.2020